ImmunoCellular Therapeutics, Ltd., which trades on the OTC Markets under the ticker IMUC, is a Los Angeles-based company developing immune-based therapies to treat cancer. As of July 9, 2020, ImmunoCellular Therapeutics, Ltd. was trading at $0.03 per share, according to Yahoo! Finance.  ImmunoCellular’s flagship research program is called Stem-to-T-Cell. What is the Stem-to-T-Cell research initiative?…

Read More